Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

HSP27 inhibitor J2

HSP27 inhibitor J2
Contact us for more batch information
Select Batch
Purity:98%
Resource Download

HSP27 inhibitor J2

Catalog No. T7265Cas No. 2133499-85-9
HSP27 inhibitor J2 (J2) (J2) is a HSP27 inhibitor, inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$132In Stock
2 mg$195In Stock
5 mg$328In Stock
10 mg$497In Stock
25 mg$793In Stock
50 mg$1,120In Stock
100 mg$1,490In Stock
1 mL x 10 mM (in DMSO)$479In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "HSP27 inhibitor J2"

Product Introduction

Bioactivity
Description
HSP27 inhibitor J2 (J2) (J2) is a HSP27 inhibitor, inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function.
In vivo
HSP27 inhibitor (J2) on radiation-induced lung inflammation in comparison to amifostine.In gross and histological findings,J2 treatment significantly inhibited immune cell infiltration in lung tissue, revealing anti-inflammatory potential of J2.Normal lung volume, evaluated by micro-CT analysis, in J2-treated mice was higher compared to that in irradiated mice.J2-treated mice reversed radiation-induced respiratory distress.However, amifostine did not show significant radioprotective effects in comparison to that of J2.In HSP27 transgenic mice, we observed increased immune cells recruitment and decreased volume of normal lung compared to wild type mice.Increased ROS production and oxidative stress after IR were down-regulated by J2 treatment, demonstrating antioxidant property of J2.J2 may be an effective therapeutic agent for radiation-induced lung injury[1].
Animal Research
Male C57BL/6 mice (age, 6 weeks; weight, 20–25 g), and were acclimatized (n = 5 per cage) for a week before irradiation. A single dose of 75 Gy was delivered to the left lung in a single fraction using image-guided small-animal irradiator (X-RAD 320) that was equipped with a collimator system composed of 3.5-cm-thick copper to produce focal radiation beams, as well as an imaging subsystem consisting of a fluorescent screen coupled to a charge-coupled-device camera. We selected 3-mm collimators to mimic clinical SBRT conditions by irradiating only a small volume of tissue. The mice were divided into six groups (n = 6–8 per group) as follows: (1) control (C);(2) irradiation (IR) - mice were exposed to a single dose of 75 Gy delivered to the left lung in a single fraction; (3) irradiation + J2 (IR + J2) ?15 mg/kg of J2 was intraperitoneal administered on every other day after irradiation;(4) irradiation + amifostine (IR + Ami) ?100 mg/kg of amifostine were intraperitoneal administered on every other day after irradiation; (5) J2 only (J2) ?15 mg/kg of J2 were intraperitoneal administered on every other day without irradiation; (6) Amifostine only (Ami) ?100 mg/kg of amifostine were intraperitoneal administered on every other day without irradiation. On day 14, mice were sacrificed by CO2 asphyxiation, and their lung tissues were collected for analysis[1].
AliasJ2
Chemical Properties
Molecular Weight264.3
FormulaC13H12O4S
Cas No.2133499-85-9
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 22.5 mg/mL (85.13 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7836 mL18.9179 mL37.8358 mL189.1790 mL
5 mM0.7567 mL3.7836 mL7.5672 mL37.8358 mL
10 mM0.3784 mL1.8918 mL3.7836 mL18.9179 mL
20 mM0.1892 mL0.9459 mL1.8918 mL9.4589 mL
50 mM0.0757 mL0.3784 mL0.7567 mL3.7836 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords